Standard BioTools
LAB
#8137
Rank
โ‚ฌ0.30 B
Marketcap
0,77ย โ‚ฌ
Share price
10.29%
Change (1 day)
-37.43%
Change (1 year)

Revenue for Standard BioTools (LAB)

Revenue in 2026 (TTM): โ‚ฌ73.64 Million

According to Standard BioTools's latest financial reports the company's current revenue (TTM ) is โ‚ฌ75.68 Million. In 2025 the company made a revenue of โ‚ฌ72.63 Million a decrease over the revenue in the year 2024 that were of โ‚ฌ0.13 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Standard BioTools from 2010 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ73.64 M1.39%
2025 โ‚ฌ72.63 M-44.76%
2024 โ‚ฌ0.13 B36.7%
2023 โ‚ฌ96.19 M5.35%
2022 โ‚ฌ91.31 M-20.81%
2021 โ‚ฌ0.11 B2.66%
2020 โ‚ฌ0.11 B7.31%
2019 โ‚ฌ0.10 B5.99%
2018 โ‚ฌ98.74 M16.23%
2017 โ‚ฌ84.95 M-14.44%
2016 โ‚ฌ99.29 M-5.35%
2015 โ‚ฌ0.10 B9.57%
2014 โ‚ฌ95.75 M85.77%
2013 โ‚ฌ51.54 M30.28%
2012 โ‚ฌ39.56 M19.86%
2011 โ‚ฌ33 M30.82%
2010 โ‚ฌ25.23 M